Oxford R21/Matrix-M™ malaria vaccine receives WHO recommendation for use paving the way for global...
The highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax’s adjuvant is critical to reducing over half a million malaria-related deaths...
ox.ac.uk